UK Companies House feature
NEOSS LIMITED
Profile
- Company number
- 04120053
- Status
- Active
- Incorporation
- 2000-11-30
- Last accounts made up
- 2024-12-31
- Account category
- GROUP
- Primary SIC
- 32500
- Hubs
- UK Healthcare
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated (group)
- Auditor
- Grant Thornton UK LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“We draw attention to note 1.2 in the financial statements, which indicates that under management's severe but plausible forecasts, the group's ability to continue to meet its liabilities as they fall due during the going concern assessment period is dependent on obtaining additional financing. The additional financing is not yet formally in place. As stated in note 1.2, these events or conditions, along with the other matters as set forth in note 1.2, indicate that a material uncertainty exists that may cast significant doubt on the group's and the parent company's ability to continue as a going concern.”
Subsidiaries
- Neoss GmbH · 100% held · Germany · Dental Implants
- Neoss Australia Pty. Ltd · 100% held · Australia · Dental Implants
- Neoss Italia S.r.l · 100% held · Italy · Dental Implants
- Neoss AB · 100% held · Sweden · Head Office Function
- Neoss Inc. · 100% held · USA · Dental Implants
- Neoss Shanghai · 100% held · China · Dental Implants
- Neoss UK & Ireland Limited · 100% held · UK · Dental Implants
- Neoss Norden AB · 100% held · Sweden · Dental Implants
- Neoss AG · 100% held · Switzerland · Head Office Function
- Arc Solutions AB · 100% held · Sweden · Milling of Restorations
Significant events
- “In September 2024, the company reached an agreement with its investors to convert the outstanding debt into equity, strengthening the Group's balance sheet and improving its liquidity position. Additionally, the current investors made a further equity injection in the same month.”
- “After the year end, the Company entered into a new bank loan agreement providing additional funding to enhance liquidity and support planned investments in production capacity, digital infrastructure, and market expansion activities.”
- “In April and June 2025 Neoss entered into two new loans, further details can be found in note 25.”
- “In June 2025 Neoss entered a term loan with HSBC for £1.75m. This loan is repayable in 60 monthly payments and funds were drawn down in August 2025. The interest rate on this loan is linked to base rate.”
- “In April 2025 Neoss entered into a loan with GHP Healthcare Holdings Limited for £1.2m. This loan is repayable upon the 3rd anniversary of its drawdown. The interest rate on this loan is 6.5%.”
- “During 2024 the company entered into an agreement with its investors to convert £22,308,744 of outstanding debt into Ordinary Shares. The company issued 46,372,399 Ordinary shares with a par value of £0.001 in exchange for the full settlement of the debt. Ordinary share classes A-D were also removed as part of the above agreement. Also during 2024, the company received an equity injection of £5,890,133 from the existing investors. This injection was in exchange for the issuance of 12,243,052 new Ordinary shares at a price of £0.48 per share.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 18 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BOUSFIELD, Nicholas Robin | Director | 2024-03-01 | Apr 1979 | British |
| CHEN, Guang, Dr | Director | 2024-05-20 | Sep 1980 | Chinese |
| HENDERSON, Ian James | Director | 2025-09-11 | Dec 1985 | British |
Show 18 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ENGMAN, Nils Fredrik | Secretary | 2001-01-11 | 2008-03-26 |
| LEAVER, Guy Cameron | Secretary | 2008-03-26 | 2022-04-01 |
| MERTON JONES, Emma | Secretary | 2022-04-01 | 2025-05-16 |
| LUPFAW SECRETARIAL LIMITED | Corporate Secretary | 2000-11-30 | 2001-01-11 |
| BARNARD, Paul Michael | Director | 2002-03-27 | 2007-07-01 |
| BOEGLI, Thomas Fritz, Dr | Director | 2022-03-23 | 2024-02-29 |
| BROWALL, Carsten Nils Eric | Director | 2004-05-01 | 2009-10-19 |
| DORMER, Michael John | Director | 2008-03-03 | 2020-12-21 |
| ENGMAN, Nils Fredrik | Director | 2001-01-11 | 2024-02-29 |
| GOTTLANDER, Robert, Mr. | Director | 2020-12-21 | 2025-05-10 |
| KENNY, James Francis | Director | 2003-04-11 | 2020-12-21 |
| LEAVER, Guy Cameron | Director | 2014-02-25 | 2022-04-01 |
| LOVELL, David John | Director | 2002-03-27 | 2003-05-31 |
| MEREDITH, Neil, Prof | Director | 2001-01-11 | 2014-05-08 |
| RAMSER, Ruth, Ms. | Director | 2020-12-21 | 2024-02-29 |
| TINSLEY, Denis Knowles | Director | 2005-04-01 | 2020-09-21 |
| WREFORD, Matthew Thomas Yardley | Director | 2003-04-11 | 2005-04-01 |
| LUPFAW FORMATIONS LIMITED | Corporate Director | 2000-11-30 | 2001-01-11 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Carecapital Implant Limited | Corporate entity | Shares 75–100% | 2020-12-21 | Active |
| Mmc Ventures Limited | Corporate entity | Voting 25–50% | 2016-04-06 | Ceased 2020-12-21 |
Filing timeline
Last 20 of 213 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-03-13 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2026-01-04 | AA | accounts | accounts with accounts type group |
| 2025-12-31 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-12-30 | CH01 | officers | change person director company with change date |
| 2025-09-23 | AP01 | officers | appoint person director company with name date |
| 2025-05-22 | TM01 | officers | termination director company with name termination date |
| 2025-05-16 | TM02 | officers | termination secretary company with name termination date |
| 2024-12-28 | SH01 | capital | capital allotment shares |
| 2024-12-28 | SH02 | capital | capital alter shares consolidation |
| 2024-12-28 | RESOLUTIONS | resolution | resolution |
| 2024-12-28 | RESOLUTIONS | resolution | resolution |
| 2024-12-28 | MA | incorporation | memorandum articles |
| 2024-12-24 | SH08 | capital | capital name of class of shares |
| 2024-12-24 | SH10 | capital | capital variation of rights attached to shares |
| 2024-12-11 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-11-26 | AA | accounts | accounts with accounts type group |
| 2024-10-18 | RP04SH01 | capital | second filing capital allotment shares |
| 2024-09-30 | SH01 | capital | capital allotment shares |
| 2024-09-17 | SH01 | capital | capital allotment shares |
| 2024-05-21 | AP01 | officers | appoint person director company with name date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory